Zobrazeno 1 - 10
of 2 864
pro vyhledávání: '"Ropinirole"'
Autor:
Ali, Samer Khalid1 samerkhalidali@gmail.com, Al-Akkam, Entidhar Jasim Muhammed1
Publikováno v:
Journal of Advanced Pharmacy Education & Research [JAPER]. Oct-Dec2023, Vol. 13 Issue 4, p8-15. 8p.
Autor:
Samer K. Ali, Entidhar J. Al-Akkam
Publikováno v:
مجلة كلية الطب, Vol 66, Iss 2 (2024)
Background: Ropinirole hydrochloride is a non-ergoline antiparkinson drug. It is a highly hydrophilic drug and classified as class III according to Biopharmaceutical Classification System with low absolute oral bioavailability of approximately 50% up
Externí odkaz:
https://doaj.org/article/419bb63a683d4a9c970065e90b472ed7
Autor:
Huang, Chenrong1,2, Wang, Ziteng1, Liu, Linsheng2, Liu, Xiaoxue2, Dong, Ji2, Xu, Qingqing1, Zhang, Bin3 zbnuclmd@126.com, Miao, Liyan1,2 miaolysuzhou@163.com
Publikováno v:
Xenobiotica. Feb2019, Vol. 49 Issue 2, p143-151. 9p.
Autor:
Heneghan, Liam J, Tsang, Amanda, Dimino, Cara, Khandji, Alexander G, Panigrahi, Sunil K, Page-Wilson, Gabrielle
Publikováno v:
Journal of Clinical Endocrinology & Metabolism; Feb2024, Vol. 109 Issue 2, pe667-e674, 8p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 39, Iss 11, Pp 1119-1128 (2023)
Abstract The primary objective of this study was to investigate the protective effects of ropinirole (ROP) medication given for an extended period following the induction of cognitive decline, oxidative stress, and deterioration of mitochondria in a
Externí odkaz:
https://doaj.org/article/1f63875e657c4def8521f55ab58422b0
Publikováno v:
Chemical Biology & Drug Design. Sep2018, Vol. 92 Issue 3, p1597-1609. 13p.
Autor:
Collo, Ginetta1,2,3, Cavalleri, Laura1, Bono, Federica1, Mora, Cristina1, Fedele, Stefania2, Invernizzi, Roberto William4, Gennarelli, Massimo1,5, Piovani, Giovanna1, Kunath, Tilo6, Millan, Mark J.7, Merlo Pich, Emilio8, Spano, PierFranco1,3
Publikováno v:
Neural Plasticity. 2/4/2018, p1-15. 15p.
Autor:
Kani, Shakul Hameed Musthafa, Sathiq, Mohamed Kani Anwar, Syed Abuthahir, Syed Mohamed Syed Ismail, Sheit, Hameed Mohamed Kasim, Raja, Maharajan
Publikováno v:
Materials Protection (0351-9465); 2023, Vol. 64 Issue 4, p452-467, 16p
Autor:
Aamir Hayyat, Nabeel Siddique
Publikováno v:
Pharmaceutical Sciences and Research, Vol 10, Iss 2, Pp 107-116 (2023)
Ropinirole HCl is a non-ergoline dopamine agonist which is recommended for the treatment of both Parkinson’s disease and Restless Legs Syndrome (RLS). Its half-life is about 6 hours and it is metabolized in the liver primarily by CYP1A2. Its metabo
Externí odkaz:
https://doaj.org/article/aff0c75866884c9992fe7ef819b174b1